CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock	Common Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2022				20,000,000	20,000,000
Beginning balance at Dec. 31, 2022	$ 10,023	$ (220)	$ 9,803	$ 2	$ 2	$ 11,928	$ (220)	$ 11,708	$ (1,907)	$ (1,907)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	88								88
Net income	814					814
Ending balance (in shares) at Mar. 31, 2023				20,000,000
Ending balance at Mar. 31, 2023	$ 10,705			$ 2		12,522			(1,819)
Beginning balance (in shares) at Dec. 31, 2023	20,000,000			20,000,000
Beginning balance at Dec. 31, 2023	$ 9,402			$ 2		11,392			(1,992)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	(185)								(185)
Net income	$ 1,378					1,378
Ending balance (in shares) at Mar. 31, 2024	20,000,000			20,000,000
Ending balance at Mar. 31, 2024	$ 10,595			$ 2		$ 12,770			$ (2,177)